ClinicalTrials.Veeva

Menu

Exposure Initializes Therapy - Treatment Of Homebound Patients Extended (ExITTOHoPE)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Unknown

Conditions

Agoraphobia

Treatments

Behavioral: cognitive behavioral therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT04460378
ChariteAmb

Details and patient eligibility

About

Cognitive behavioral treatment of homebound patients with severe agoraphobia.

Full description

Homebound patients with severe agoraphobia are treated with an exposure focussed cognitive behavioral therapy. The treatment begins at home. With a quick onset of guided exposure, patients get the possibility to develope the capability to reach the regular Treatment Location on their own very rapidly.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • agoraphobia with/without Panic disorder

Exclusion criteria

  • psychotic disorders
  • bipolar disorders
  • acute substance dependency

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Cognitive Behavioral Therapy
Experimental group
Description:
Manualized Cognitive Behavioral Therapy starting at the patients' home.
Treatment:
Behavioral: cognitive behavioral therapy

Trial contacts and locations

1

Loading...

Central trial contact

Jens Plag, Dr.; Carolin Liebscher, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems